|1.||Bernard, Olivier A: 1 article (05/2015)|
|2.||Johansen, Jens V: 1 article (05/2015)|
|3.||Bagger, Frederik O: 1 article (05/2015)|
|4.||Jia, Guangshuai: 1 article (05/2015)|
|5.||Rapin, Nicolas: 1 article (05/2015)|
|6.||Helin, Kristian: 1 article (05/2015)|
|7.||Pedersen, Marianne T: 1 article (05/2015)|
|8.||Christensen, Jesper: 1 article (05/2015)|
|9.||Rasmussen, Kasper D: 1 article (05/2015)|
|10.||Porse, Bo T: 1 article (05/2015)|
10/17/2012 - "We surveyed the landscape of DNA methylation alterations in gastric cancer by analyzing genome-wide CG dinucleotide (CpG) methylation profiles of 240 gastric cancers (203 tumors and 37 cell lines) and 94 matched normal gastric tissues. "
03/26/2015 - "Intratumoral injection of an unmethylated cytosine guanine dinucleotide (CpG)-enriched oligodeoxynucleotide, an agonist for the toll-like receptor 9 (TLR9), induces the activation of natural killer cells, macrophages, and antigen presenting cells that control tumor growth at the local site. "
01/15/2014 - "Promoter methylation status and gene expression were assessed in a large panel of head and neck primary tumors, based on the hypothesis that cytosine-guanine dinucleotide (CpG) hypermethylation might silence the galanin receptor 2 (GALR2) gene. "
|2.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/01/2015 - "The methylcytosine dioxygenase TET2 is frequently mutated in hematological disorders, including acute myeloid leukemia (AML), and has been suggested to protect CG dinucleotide (CpG) islands and promoters from aberrant DNA methylation. "
01/08/2015 - "Acute myeloid leukemia (AML) is associated with deregulation of DNA methylation; however, many cases do not bear mutations in known regulators of cytosine guanine dinucleotide (CpG) methylation. "
|3.||Melanoma (Melanoma, Malignant)
10/01/2010 - "We have shown that immunization with dendritic cells (DCs) pulsed with hepatitis B virus core antigen virus-like particles (HBc-VLP) packaging with cytosine-guanine dinucleotide (CpG) (HBc-VLP/CpG) alone were able to delay melanoma growth but not able to eradicate the established tumour in mice. "
12/01/2012 - "Immunohistological analysis of in-transit metastasis in a patient with advanced melanoma treated with combination therapy of cytosine guanine dinucleotide oligodeoxynucleotide, dacarbazine and beta-interferon: a case report."
01/01/2005 - "Do cytosine guanine dinucleotide (CpG) fragments induce vasoactive neuropeptide mediated fatigue-related autoimmune disorders?"
01/01/2005 - "Complex mechanisms involving heat shock proteins (hsps) and cytosine-guanine dinucleotide (CpG) DNA fragments may also be associated with autoimmunity to VNs or their GPCRs in contributing to fatigue-related conditions. "
09/01/2006 - "The purpose of this prospective study was to enumerate Toll-like receptor 9 (TLR9)(+) cells and measure their function using synthetic oligonucleotides enriched in CG dinucleotide motifs (CpG)-induced proliferation within 48 h after trauma in severely injured patients prone to sepsis. "
|1.||DNA (Deoxyribonucleic Acid)
|2.||Toll-Like Receptor 9
|3.||Type 2 Galanin Receptor
|5.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|6.||Transcription Factors (Transcription Factor)
|9.||Heat-Shock Proteins (Heat-Shock Protein)
|10.||Factor IX (PTC)